Physician profile
Ryan T Rogers
NPI 1396065470
$1,240.43
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $682 · 2020: $377 · 2021: $65.76 · 2022: $18.25 · 2023: $98.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $98.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $98.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $446.34 | 2019-2023 | Skyrizi |
| Galderma Laboratories, L.P. | $278.69 | 2019-2020 | |
| Genzyme Corporation | $98.89 | 2020-2023 | |
| Celgene Corporation | $95.08 | 2019 | |
| Amgen INC. | $89.03 | 2020-2023 | Otezla |
| Lilly USA, LLC | $35.06 | 2019 | |
| Sun Pharmaceutical Industries INC. | $24.60 | 2019 | |
| Arcutis Biotherapeutics, INC. | $22.86 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $22.59 | 2019 | |
| Janssen Biotech, INC. | $18.35 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $17.87 | 2023 | Sotyktu |
| Almirall LLC | $17.15 | 2019 | |
| Genentech USA, INC. | $17.15 | 2019 | |
| Misonix INC | $15.07 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $14.50 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $14.19 | 2021 | |
| Pfizer INC. | $13.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.